Table 2 GRADE assessment, the quality of evidence evaluated considering direct evidence, indirect evidence, and network meta-analysis evidence. Network meta-analysis evidence are calculated using the Bayesian method
Comparison | Direct evidence | Indirect evidence | Network meta-anaalysis | |||
|---|---|---|---|---|---|---|
SMD (95% CI) | Quality of evidence | SMD (95% CI) | Quality of evidence | SMD (95% CI) | Quality of evidence | |
ESPB versus placebo | - | - | -22.93(-34.29;-11.57) | ⊕ ⊕ ⊝ ⊝ Low | -22.93(-34.29;-11.57) | ⊕ ⊕ ⊝ ⊝ Low |
PIFB versus placebo | -6.57(-14.52;1.39) | ⊕ ⊕ ⊝ ⊝ Low | -11.97(-28.41;4.46) | ⊕ ⊝ ⊝ ⊝ Very Low | -7.59(-14.75;-0.44) | ⊕ ⊕ ⊝ ⊝ Low |
TTMPB versus placebo | -11.47 (-18.36;-4.59) | ⊕ ⊕ ⊝ ⊝ Low | -6.07(-22.98;10.84) | ⊕ ⊝ ⊝ ⊝ Very Low | -10.70(-17.08; -4.32) | ⊕ ⊕ ⊝ ⊝ Low |
ESPB versus PIFB | - | - | -15.34(-28.77;-1.91) | ⊕ ⊝ ⊝ ⊝ Very Low | -15.34(-28.77;-1.91) | ⊕ ⊝ ⊝ ⊝ Very Low |
ESPB versus TTMPB | - | - | -12.23(-25.25;0.80) | ⊕ ⊝ ⊝ ⊝ Very Low | -12.23(-25.25;0.80) | ⊕ ⊝ ⊝ ⊝ Very Low |
PIFB versus TTMPB | -0.50 (-15.42;14.42) | ⊕ ⊕ ⊝ ⊝ Low | 4.90(-5.61;15.42) | ⊕ ⊝ ⊝ ⊝ Very Low | 3.11(-5.48; 11.70) | ⊕ ⊕ ⊝ ⊝ Low |